These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 28427560)

  • 1. Stress-Adaptive Response in Ovarian Cancer Drug Resistance: Role of TRAP1 in Oxidative Metabolism-Driven Inflammation.
    Amoroso MR; Matassa DS; Agliarulo I; Avolio R; Maddalena F; Condelli V; Landriscina M; Esposito F
    Adv Protein Chem Struct Biol; 2017; 108():163-198. PubMed ID: 28427560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative metabolism drives inflammation-induced platinum resistance in human ovarian cancer.
    Matassa DS; Amoroso MR; Lu H; Avolio R; Arzeni D; Procaccini C; Faicchia D; Maddalena F; Simeon V; Agliarulo I; Zanini E; Mazzoccoli C; Recchi C; Stronach E; Marone G; Gabra H; Matarese G; Landriscina M; Esposito F
    Cell Death Differ; 2016 Sep; 23(9):1542-54. PubMed ID: 27206315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol Homeostasis Modulates Platinum Sensitivity in Human Ovarian Cancer.
    Criscuolo D; Avolio R; Calice G; Laezza C; Paladino S; Navarra G; Maddalena F; Crispo F; Pagano C; Bifulco M; Landriscina M; Matassa DS; Esposito F
    Cells; 2020 Mar; 9(4):. PubMed ID: 32235572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of Mitochondrial Metabolic Reprogramming and Oxidative Stress to Overcome Chemoresistance in Cancer.
    Avolio R; Matassa DS; Criscuolo D; Landriscina M; Esposito F
    Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31947673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRAP1 downregulation in human ovarian cancer enhances invasion and epithelial-mesenchymal transition.
    Amoroso MR; Matassa DS; Agliarulo I; Avolio R; Lu H; Sisinni L; Lettini G; Gabra H; Landriscina M; Esposito F
    Cell Death Dis; 2016 Dec; 7(12):e2522. PubMed ID: 27977010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heat shock proteins, cell survival and drug resistance: the mitochondrial chaperone TRAP1, a potential novel target for ovarian cancer therapy.
    Landriscina M; Amoroso MR; Piscazzi A; Esposito F
    Gynecol Oncol; 2010 May; 117(2):177-82. PubMed ID: 19942270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRAP1 role in endoplasmic reticulum stress protection favors resistance to anthracyclins in breast carcinoma cells.
    Sisinni L; Maddalena F; Lettini G; Condelli V; Matassa DS; Esposito F; Landriscina M
    Int J Oncol; 2014 Feb; 44(2):573-82. PubMed ID: 24297638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRAP1 controls cell migration of cancer cells in metabolic stress conditions: Correlations with AKT/p70S6K pathways.
    Agliarulo I; Matassa DS; Amoroso MR; Maddalena F; Sisinni L; Sepe L; Ferrari MC; Arzeni D; Avolio R; Paolella G; Landriscina M; Esposito F
    Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2570-9. PubMed ID: 26071104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overcoming cisplatin resistance of ovarian cancer cells by targeting HIF-1-regulated cancer metabolism.
    Ai Z; Lu Y; Qiu S; Fan Z
    Cancer Lett; 2016 Apr; 373(1):36-44. PubMed ID: 26801746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRAP1 enhances Warburg metabolism through modulation of PFK1 expression/activity and favors resistance to EGFR inhibitors in human colorectal carcinomas.
    Maddalena F; Condelli V; Matassa DS; Pacelli C; Scrima R; Lettini G; Li Bergolis V; Pietrafesa M; Crispo F; Piscazzi A; Storto G; Capitanio N; Esposito F; Landriscina M
    Mol Oncol; 2020 Dec; 14(12):3030-3047. PubMed ID: 33025742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PGC1α regulates mitochondrial oxidative phosphorylation involved in cisplatin resistance in ovarian cancer cells via nucleo-mitochondrial transcriptional feedback.
    Shen L; Zhou L; Xia M; Lin N; Ma J; Dong D; Sun L
    Exp Cell Res; 2021 Jan; 398(1):112369. PubMed ID: 33220258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRAP1 Regulation of Cancer Metabolism: Dual Role as Oncogene or Tumor Suppressor.
    Matassa DS; Agliarulo I; Avolio R; Landriscina M; Esposito F
    Genes (Basel); 2018 Apr; 9(4):. PubMed ID: 29621137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mitochondrial HSP90 paralog TRAP1 forms an OXPHOS-regulated tetramer and is involved in mitochondrial metabolic homeostasis.
    Joshi A; Dai L; Liu Y; Lee J; Ghahhari NM; Segala G; Beebe K; Jenkins LM; Lyons GC; Bernasconi L; Tsai FTF; Agard DA; Neckers L; Picard D
    BMC Biol; 2020 Jan; 18(1):10. PubMed ID: 31987035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of TRAP1 Accelerates the DNA Damage Response, Activation of the Heat Shock Response and Metabolic Reprogramming in Colon Cancer Cells.
    Bhasin N; Dabral P; Senavirathna L; Pan S; Chen R
    Front Biosci (Landmark Ed); 2023 Sep; 28(9):227. PubMed ID: 37796715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial oxidative phosphorylation TRAP(1)ped in tumor cells.
    Rasola A; Neckers L; Picard D
    Trends Cell Biol; 2014 Aug; 24(8):455-63. PubMed ID: 24731398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer.
    Deng J; Wang L; Chen H; Hao J; Ni J; Chang L; Duan W; Graham P; Li Y
    Oncotarget; 2016 Aug; 7(34):55771-55788. PubMed ID: 27304054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of mitochondrial chaperone TRAP1 in ulcerative colitis associated colorectal cancer.
    Chen R; Pan S; Lai K; Lai LA; Crispin DA; Bronner MP; Brentnall TA
    World J Gastroenterol; 2014 Dec; 20(45):17037-48. PubMed ID: 25493016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of TRAP1 and estrogen receptor alpha in patients with ovarian cancer -a study of the OVCAD consortium.
    Aust S; Bachmayr-Heyda A; Pateisky P; Tong D; Darb-Esfahani S; Denkert C; Chekerov R; Sehouli J; Mahner S; Van Gorp T; Vergote I; Speiser P; Horvat R; Zeillinger R; Pils D
    Mol Cancer; 2012 Sep; 11():69. PubMed ID: 22978347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic orchestration between cancer cells and tumor microenvironment as a co-evolutionary source of chemoresistance in ovarian cancer: a therapeutic implication.
    Suh DH; Kim HS; Kim B; Song YS
    Biochem Pharmacol; 2014 Nov; 92(1):43-54. PubMed ID: 25168677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression and significance of tumor necrosis factor receptor associated protein 1 in epithelial ovarian cancer].
    Ma RQ; Cheng HY; Ye X; Chen J; Cui H; Wei LH; Chang XH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Feb; 46(1):120-4. PubMed ID: 24535363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.